spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  NexACT 

 HSMN NewsFeed - 13 Nov 2013
Apricus and Laboratoires Majorelle Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream Vitaros(R) in France, Monaco and Certain African Countries
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 10 Jun 2013
Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Sep 2012
Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Feb 2012
Toshiba’s Aquilion PRIME CT System Receives FDA Clearance
Devices Radiology FDA
 HSMN NewsFeed - 20 May 2009
Toshiba Introduces New Multi-Detector CT Systems
Devices Radiology
 HSMN NewsFeed - 3 Feb 2009
Warner Chilcott Announces Agreement to Acquire Topical Alprostadil Treatment for Erectile Dysfunction
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Nov 2007
Toshiba Launches Breakthrough CT System -- the AquilionONE
Devices Radiology
 HSMN NewsFeed - 20 Nov 2007
NexMed Confirms FDA Acceptance of NDA for Erectle Dysfunction Product
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Nov 2007
NexMed Appoints Hem Pandya as Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 24 Sep 2007
NexMed Files NDA for Proprietary Erectile Dysfunction Treatment
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Jun 2007
NexMed Appoints Vivian Liu as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2007
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2006
Threshold Pharmaceuticals Announces Change in Guidance for Release of Phase 3 Trial Results in Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
Biopharmaceuticals Drug Delivery Licensing Distribution
Return to NewsFeed  

 Additional items found! 11

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 11 additional stories matching:
NexACT
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.